Stay updated with breaking news from Large Ischemic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
1. Patients in the thrombectomy plus medical care group reported a significantly lower mRS score at the 1-year follow-up compared to those in the medical care alone group. 2. 1-year mortality in the thrombectomy group was lower than in the medical care alone group. Evidence Rating Level: 1 (Excellent) Study Rundown: Endovascular thrombectomy is known
1. Patients in the thrombectomy group reported significantly greater improvement, with lower mortality at 90 days versus medical management alone. 2. Symptomatic intracranial hemorrhage was comparable between groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Patients with acute ischemic stroke and large vessel infarct benefit from endovascular thrombectomy. However, previous studies have shown clinical benefits using
1. Patients in the thrombectomy group reported significantly greater improvement, with lower mortality at 90 days versus medical management alone. 2. Symptomatic intracranial hemorrhage was comparable between groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Patients with acute ischemic stroke and large vessel infarct benefit from endovascular thrombectomy. However, previous studies have shown clinical benefits
1. Median modified Rankin Scale score at 90 days was lower in the endovascular group, indicating improved outcomes. 2. Symptomatic intracranial bleeding was more prominent in the intervention group than control. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous guidelines support the use of endovascular treatment for patients with anterior circulation artery-related ischemic stroke within
The annual International Stroke Conference of the American Heart Association/American Stroke Association was held from Feb. 8 to 10 in Dallas and attracted participants from around the world, including cerebrovascular